Prof. Jacques Séguin, Famend Inventor of CoreValve, Joins Endoron Medical as Chairman of the Board

Distinguished surgeon and founder is thought for efficiently bringing medtech improvements to the market by way of acquisitions by main trade gamers

TEL AVIV, ISRAEL / ACCESSWIRE / February 1, 2023 / Endoron Medical, (“Endoron”), a medical system firm growing an revolutionary answer for endovascular restore of stomach aortic aneurysms (AAA), at the moment introduced that Prof. Jacques Séguin will be part of its board of administrators as chairman.

Endoron Medical, Wednesday, February 1, 2023, Press release picture

Endoron Medical, Wednesday, February 1, 2023, Press launch image

Séguin, Professor of Cardiac Surgical procedure at Paris College, holds a Ph.D. in Biochemistry and Medical Historical past and has greater than 20 years of expertise performing over 4,000 open-heart surgical procedures and authoring greater than 200 articles in peer-reviewed worldwide medical journals.

Prof. Séguin is thought for having made lasting contributions to the sphere of medical expertise by way of the event of revolutionary options, together with the self-expandable TAVR process, developed by CoreValve, an organization he based which was subsequently acquired by Medtronic for over $800 million in 2009. The CoreValve revalving system was the primary TAVR (Transcatheter aortic valve alternative) system to obtain the CE Mark in 2007 and has already helped 25,000 coronary heart illness victims worldwide.[1]

Prof. Séguin was additionally a part of the unique workforce at ReCor Medical, a renal denervation firm based by Sofinnova Companions and purchased by the Japanese firm Otsuka in 2018. Each CoreValve and ReCor Medical have been funded by Sofinnova Companions on the collection A stage. Prof. Seguin additionally based Stentys and is presently the Chairman of Picardia, that are additionally corporations backed by Sofinnova Companions,

“I am honored to be becoming a member of Endoron to help the emergence of Aortoseal in scientific observe,” he mentioned. “The expertise developed by Endoron mimics the hand-sewn graft of open surgical procedure and is on observe to unravel the principle situation of endovascular aneurysm restore: long-term sturdiness. I am satisfied that Endoron is bringing a game-changing expertise to the EVAR market with a really disruptive strategy.”

“We’re proud and delighted to have Prof. Seguin be part of our board as chairman, at a pivotal time for the corporate,” mentioned Ronit Harpaz, Co-Founder and Chief Govt Officer of Endoron. “Together with his in depth and profitable observe file within the medtech discipline, Prof. Séguin brings to Endoron a deep data and experience to assist us advance our revolutionary expertise to the clinic. We sit up for working collectively to offer AAA sufferers present process endovascular aneurysm restore with a long-lasting sealing and fixation answer for his or her endograft expertise.”


About Endoron Medical
Endoron Medical is a portfolio firm of Sofinnova Partners, a number one European life sciences enterprise capital agency primarily based in Paris, London, and Milan. The corporate was seed financed by Sofinnova MD Start, the agency’s in-house medtech accelerator. Endoron is growing an endovascular suturing system to forestall long-term issues within the therapy of stomach aortic aneurysms. For additional info, go to

Ronit Harpaz
Chief Govt Officer, Endoron Medical
[email protected]

[1], “Corevalve”, [accessed date: Jan 21st, 2023]

SOURCE: Endoron Medical

View supply model on

Previous post Chiefs QB Patrick Mahomes’ AFC Championship Recreation sizzle reel has good tune selection
Next post Michael Schumacher Drove This Race Automotive in His Components 1 Debut. Now It’s Up for Grabs.